Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Lexicon Pharmaceuticals, Inc. (LXRX)

-NasdaqGS
1.67 0.00(0.00%) Jul 11, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 2,222   1,089   1,849  
Cost of Revenue -   -   -  
Gross Profit 2,222   1,089   1,849  
Operating Expenses
Research Development89,682  82,574  91,828  
Selling General and Administrative14,911  26,930  24,116  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (102,371) (108,415) (114,095)
Income from Continuing Operations
Total Other Income/Expenses Net216  318  408  
Earnings Before Interest And Taxes(102,155)(108,097)(113,687)
Interest Expense1,971  2,114  2,528  
Income Before Tax(104,126)(110,211)(116,215)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(104,126)(110,211)(116,215)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (104,126) (110,211) (116,215)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (104,126) (110,211) (116,215)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.